Alessandra d'Azzo, PhD
Alessandra d'Azzo, PhD

Alessandra d'Azzo, PhD

Member, St. Jude Faculty

  • Jewelers For Children Endowed Chair in Genetics and Gene Therapy



MS – University of Pavia, Italy (1979)
PhD – University of Milano, Italy (1973)
PhD – Erasmus University, Rotterdam, The Netherlands (1982)

Research Highlights

  • In animal models of pediatric lysosomal storage diseases, we study mechanisms of pathogenesis downstream of lysosomal enzymes that are also implicated in adult diseases and aging (i.e. Alzheimer’s Disease, fibrosis, and cancer).
  • In animal models of OZZ and its target substrates, we study the regulation of cytoskeletal-associated proteins, and membrane dynamics.

Lysosomal Biogenesis and Lysosomal Storage Diseases

Therapy for Lysosomal Storage Diseases

Regulation and function of OZZ-E3, a muscle-specific ubiquitin ligase complex

d'Azzo Lab Members

Selected Publications

Neves JC, Rizzato VR, Fappi A, Garcia MM, Chadi G, Van De Vlekkert D, D'azzo A, Zanoteli E. Neuraminidase-1 mediates skeletal muscle regeneration. Biochim Biophys Acta 1852(9):1755-64, 2015.

Akgoc Z, Sena-Esteves M, Martin DR, Han X, D'azzo A, Seyfried TN. Bis(monoacylglycero)phosphate: A secondary storage lipid in the gangliosidoses. J Lipid Res 56(5):1006-13, 2015.

Heinecke KA, Luoma A, D'azzo A, Kirschner DA, Seyfried TN. Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosis. ASN Neuro. 2015 Feb 18;7(1). pii: 1759091415568913. doi: 10.1177/1759091415568913.

Annunziata I, Patterson A, D'azzo A. Isolation of mitochondria-associated er membranes (MAMs) and glycosphingolipid-enriched micro domains (GEMs) from brain tissues and neuronal cells. Methods Mol Biol 1264:25-33, 2015.

Bonardi D, Ravasio V, Borsani G, D'azzo A, Bresciani R, Monti E, Giacopuzzi E. In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization. PLoS One 9(8):e104229, 2014.

Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, Van De Vlekkert D, D'azzo A, Zheng P, Liu Y. Broad and direct interaction between tlr and siglec families of pattern recognition receptors and its regulation by NEU1. Elife 3:e04066, 2014.

Katorcha E, Makarava N, Savtchenko R, D'azzo A, Baskakov IV. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of prpsc glycoform and prion infectivity. PLoS Pathog 10(9):e1004366, 2014.

Bonten EJ, Annunziata I, D'azzo A. Lysosomal multienzyme complex: Pros and cons of working together. Cell Mol Life Sci 71(11):2017-32, 2014.

Annunziata I, D'azzo A. Interorganellar membrane microdomains: Dynamic platforms in the control of calcium signaling and apoptosis. Cells 2(3):574-90, 2013.

Caciotti A, Catarzi S, Tonin R, Lugli L, Perez CR, Michelakakis H, Mavridou I, Donati MA, Guerrini R, D'azzo A, Morrone A. Galactosialidosis: Review and analysis of ctsa gene mutations.Orphanet J Rare Dis 8:114, 2013.

Annunziata I, Patterson A, D'azzo A. Mitochondria-associated er membranes (MAMs) and glycosphingolipid enriched micro domains (GEMs): Isolation from mouse brain. J Vis Exp(73):e50215, 2013.

Annunziata I, Patterson A, Helton D, Hu H, Moshiach S, Gomero E, Nixon R, D'azzo A. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-beta secretion via deregulated lysosomal exocytosis. Nat Commun 4:2734, 2013.

Bonten EJ, Yogalingam G, Hu H, Gomero E, Van De Vlekkert D, D'azzo A. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type i sialidosis. Biochim Biophys Acta 1832(10):1784-92, 2013.

Romancino DP, Paterniti G, Campos Y, De Luca A, Di Felice V, D'azzo A, Bongiovanni A. Identification and characterization of the nano-sized vesicles released by muscle cells. FEBS Lett587(9):1379-84, 2013.

Hu H, Gomero E, Bonten E, Gray JT, Allay J, Wu Y, Wu J, Calabrese C, Nienhuis A, D'azzo A. Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis. Mol Ther 20(2):267-74, 2012.

Bongiovanni A, Romancino DP, Campos Y, Paterniti G, Qiu X, Moshiach S, Di Felice V, Vergani N, Ustek D, D'azzo A. Alix protein is substrate of OZZ-E3 ligase and modulates actin remodeling in skeletal muscle. J Biol Chem 287(15):12159-71, 2012.

Baek RC, Broekman ML, Leroy SG, Tierney LA, Sandberg MA, D'azzo A, Seyfried TN, Sena-Esteves M. Aav-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in cns and improves survival. PLoS One 5(10):e13468, 2010.

Monti E, Bonten E, D'azzo A, Bresciani R, Venerando B, Borsani G, Schauer R, Tettamanti G. Sialidases in vertebrates: A family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 64:403-79, 2010.

Wu X, Steigelman KA, Bonten E, Hu H, He W, Ren T, Zuo J, D'azzo A. Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Biochim Biophys Acta 1802(2):259-68, 2010.

Zanoteli E, Van De Vlekkert D, Bonten EJ, Hu H, Mann L, Gomero EM, Harris AJ, Ghersi G, D'azzo A. Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue. Biochim Biophys Acta 1802(7-8):659-72, 2010.

D'azzo A, Bonten E. Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease. Biochem Soc Trans 38(6):1453-7, 2010.

Campos Y, Qiu X, Zanoteli E, Moshiach S, Vergani N, Bongiovanni A, Harris AJ, D'azzo A. Ozz-E3 ubiquitin ligase targets sarcomeric embryonic myosin heavy chain during muscle development. PLoS One 5(3):e9866, 2010.

Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J, Forte M, D'azzo A. GM1-ganglioside accumulation at the mitochondria-associated er membranes links er stress to ca(2+)-dependent mitochondrial apoptosis. Mol Cell 36(3):500-11, 2009.

Bonten EJ, Campos Y, Zaitsev V, Nourse A, Waddell B, Lewis W, Taylor G, D'azzo A. Heterodimerization of the sialidase neu1 with the chaperone protective protein/cathepsin a prevents its premature oligomerization. J Biol Chem 284(41):28430-41, 2009.

Yogalingam G, Bonten EJ, Van De Vlekkert D, Hu H, Moshiach S, Connell SA, D'azzo A. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 15(1):74-86, 2008.

D'azzo A, Tessitore A, Sano R. Gangliosides as apoptotic signals in er stress response. Cell Death Differ 13(3):404-14, 2006.

Wang D, Bonten EJ, Yogalingam G, Mann L, D'azzo A. Short-term, high dose enzyme replacement therapy in sialidosis mice. Mol Genet Metab 85(3):181-9, 2005.

Sano R, Tessitore A, Ingrassia A, D'azzo A. Chemokine-induced recruitment of genetically modified bone marrow cells into the cns of GM1-gangliosidosis mice corrects neuronal pathology. Blood 106(7):2259-68, 2005.

D'azzo A, Bongiovanni A, Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6(6):429-41, 2005.

Bonten EJ, Wang D, Toy JN, Mann L, Mignardot A, Yogalingam G, D'azzo A. Targeting macrophages with baculovirus-produced lysosomal enzymes: Implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis. FASEB J 18(9):971-3, 2004.


Show More

Tessitore A, Del PMM, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM, D'azzo A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 15(5):753-66, 2004.

Nastasi T, Bongiovanni A, Campos Y, Mann L, Toy JN, Bostrom J, Rottier R, Hahn C, Conaway JW, Harris AJ, D'azzo A. Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis. Dev Cell 6(2):269-82, 2004.

Cuervo AM, Mann L, Bonten EJ, D'azzo A, Dice JF. Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J 22(1):47-59, 2003.

D'azzo A. Gene transfer strategies for correction of lysosomal storage disorders. Acta Haematol 110(2-3):71-85, 2003.

Leimig T, Mann L, Martin Mdel P, Bonten E, Persons D, Knowles J, Allay JA, Cunningham J, Nienhuis AW, Smeyne R, D'azzo A. Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood 99(9):3169-78, 2002.

De Geest N, Bonten E, Mann L, De Sousa-Hitzler J, Hahn C, D'azzo A. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 11(12):1455-64, 2002.

Bonten EJ, Arts WF, Beck M, Covanis A, Donati MA, Parini R, Zammarchi E, D'azzo A. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum Mol Genet 9(18):2715-25, 2000.

Hahn CN, Del Pilar Martin M, Zhou XY, Mann LW, D'azzo A. Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter. Proc Natl Acad Sci USA 95(25):14880-5, 1998.

Rottier RJ, Hahn CN, Mann LW, Del Pilar Martin M, Smeyne RJ, Suzuki K, D'azzo A. Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: Indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Hum Mol Genet 7(11):1787-94, 1998.

Van Der Spoel A, Bonten E, D'azzo A. Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J 17(6):1588-97, 1998.

Rudenko G, Bonten E, Hol WG, D'azzo A. The atomic model of the human protective protein/cathepsin a suggests a structural basis for galactosialidosis. Proc Natl Acad Sci USA 95(2):621-5, 1998.

Hahn CN, Del Pilar Martin M, Schroder M, Vanier MT, Hara Y, Suzuki K, Suzuki K, D'azzo A. Generalized cns disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Hum Mol Genet 6(2):205-11, 1997.

Bonten E, Van Der Spoel A, Fornerod M, Grosveld G D'azzo A. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev 10(24):3156-69, 1996.

Rudenko G, Bonten E, D'azzo A, Hol WG. Three-dimensional structure of the human 'protective protein': Structure of the precursor form suggests a complex activation mechanism. Structure3(11):1249-59, 1995.

Zhou XY, Morreau H, Rottier R, Davis D, Bonten E, Gillemans N, Wenger D, Grosveld FG, Doherty P, Suzuki K, Grosveld GC, D'azzo A. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev 9(21):2623-34, 1995.

Galjart NJ, Gillemans N, Harris A, Van Der Horst GT, Verheijen FW, Galjaard H, D'azzo A. Expression of cdna encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: Homology to yeast proteases. Cell 54(6):755-64, 1988.

D'azzo A, Hoogeveen A, Reuser AJ, Robinson D, Galjaard H. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA 79(15):4535-9, 1982.

Last update: July 2015